TAILIEUCHUNG - Coeliac disease - Recognition and assessment of coeliac disease

A workplan is a detailed list of the steps involved in the materials development process. It helps you to organize for upcoming steps. Figure 1 shows a very general workplan attached to a simple timeline. You can use this sample as a starting point for your own workplan. Notice that the time needed to complete the materials development process, from concept to final product, can range from six to twelve months or more. The time can vary, depending on the complexity and number of materials you are producing, the number of staff devoted to the project, and the amount of work you can contract outside your organization, such as. | NHS National Institute for Health and Clinical Excellence Issue date May 2009 Coeliac disease Recognition and assessment of coeliac disease NICE clinical guideline 86 Developed by the Centre for Clinical Practice at NICE NICE clinical guideline 86 Coeliac disease recognition and assessment of coeliac disease Ordering information You can download the following documents from CG86 The full guideline this document - all the recommendations details of how they were developed and reviews of the evidence they were based on. A quick reference guide - a summary of the recommendations for healthcare professionals. Understanding NICE guidance - a summary for patients and carers. For printed copies of the quick reference guide or Understanding NICE guidance phone NICE publications on 0845 003 7783 or email publications@ and quote N1859 quick reference guide N1860 Understanding NICE guidance . NICE clinical guidelines are recommendations about the treatment and care of people with specific diseases and conditions in the NHS in England and Wales. This guidance represents the view of NICE which was arrived at after careful consideration of the evidence available. Healthcare professionals are expected to take it fully into account when exercising their clinical judgement. However the guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient in consultation with the patient and or guardian or carer and informed by the summary of product characteristics of any drugs they are considering. Implementation of this guidance is the responsibility of local commissioners and or providers. Commissioners and providers are reminded that it is their responsibility to implement the guidance in their local context in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this guidance should be .

• Sức khỏe trẻ em
• certifications levels
• Building Investment
• Pediatric Cardiology
• Renal and Cardiovascular
• Pediatric Cardiac Surgery
• Skill and Creativity